Cleared Traditional

K093993 - LIPISCAN IVUS IMAGING SYSTEM MODEL NIRS-MC7-70 (FDA 510(k) Clearance)

Jun 2010
Decision
188d
Days
Class 2
Risk

K093993 is an FDA 510(k) clearance for the LIPISCAN IVUS IMAGING SYSTEM MODEL NIRS-MC7-70. This device is classified as a Catheter, Intravascular, Plaque Morphology Evaluation (Class II - Special Controls, product code OGZ).

Submitted by Infraredx, Inc. (Burlington, US). The FDA issued a Cleared decision on June 30, 2010, 188 days after receiving the submission on December 24, 2009.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1200. Catheter Used For Delivery Of A Sensing Modality To A Coronary Or Peripheral Artery Region For Determination Of Atherosclerotic Plaque Characteristics. For Examination Of Morphologic Features Of Coronary Or Peripheral Artery Lesions Or Plaques..

Submission Details

510(k) Number K093993 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 24, 2009
Decision Date June 30, 2010
Days to Decision 188 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code OGZ - Catheter, Intravascular, Plaque Morphology Evaluation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1200
Definition Catheter Used For Delivery Of A Sensing Modality To A Coronary Or Peripheral Artery Region For Determination Of Atherosclerotic Plaque Characteristics. For Examination Of Morphologic Features Of Coronary Or Peripheral Artery Lesions Or Plaques.